
Opinion|Videos|July 11, 2024
Recent findings from BESPOKE
Key opinion leaders analyze recent findings from the BESPOKE study.
Advertisement
Episodes in this series

- BESPOKE Interim analysis: ctDNA for informing ACT in stage II/III CRC (
Kasi, et al. ASCO GI 2024. Abstract 9. )
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Matching Neoadjuvant Therapy to Tumor Genomics in High-Risk Prostate Cancer
2
FDA Approves Perioperative Durvalumab/Enfortumab Vedotin in MIBC
3
Subsequent Therapy May Have Narrowed the Overall Survival Gap in LITESPARK-011
4
Second-Line Options and Selecting Ipilimumab Plus Nivolumab in RCC
5

